CoChat

Advanced Flow Cytometry Assays for Immune Monitoring of CAR-T Cell Applications

Open access
Blache, Ulrich, Weiss, Ronald, Boldt, Andreas, Kapinsky, Michael, Blaudszun, André-René, Quaiser, Andrea, Pohl, Annabelle, Miloud, Tewfik, Burgaud, Mégane, Vucinic, Vladan, Platzbecker, Uwe, Sack, Ulrich, Fricke, Stephan, Koehl, Ulrike · 2021 · Frontiers in Immunology
Cited by 75

The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.

Abstract

Adoptive immunotherapy using chimeric antigen receptor (CAR)-T cells has achieved successful remissions in refractory B-cell leukemia and B-cell lymphomas. In order to estimate both success and severe side effects of CAR-T cell therapies, longitudinal monitoring of the patient’s immune system including CAR-T cells is desirable to accompany clinical staging. To conduct research on the fate and immunological impact of infused CAR-T cells, we established standardized 13-colour/15-parameter flow cytometry assays that are suitable to characterize immune cell subpopulations in the peripheral blood during CAR-T cell treatment. The respective staining technology is based on pre-formulated dry antibody panels in a uniform format. Additionally, further antibodies of choice can be added to address specific clinical or research questions. We designed panels for the anti-CD19 CAR-T therapy and, as a proof of concept, we assessed a healthy individual and three B-cell lymphoma patients treated with anti-CD19 CAR-T cells. We analyzed the presence of anti-CD19 CAR-T cells as well as residual CD19+ B cells, the activation status of the T-cell compartment, the expression of co-stimulatory signaling molecules and cytotoxic agents such as perforin and granzyme B. In summary, this work introduces standardized and modular flow cytometry assays for CAR-T cell clinical research, which could also be adapted in the future as quality controls during the CAR-T cell manufacturing process.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fimmu.2021.658314

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 16 references

Cited by

See all 75

Metadata

Authors
Blache, U., Weiss, R., Boldt, A., Kapinsky, M., Blaudszun, A.-R., Quaiser, A., Pohl, A., Miloud, T., Burgaud, M., Vucinic, V., Platzbecker, U., Sack, U., Fricke, S., & Koehl, U.
Venue
Frontiers in Immunology
Published
2021-05-03
Volume
12
Pages
658314-658314
ISSN
1664-3224 (ISSN-L)
OpenAlex
W3158281789
Cited by
75
References
16
FWCI
4.00
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Advanced Flow Cytometry Assays for Immune Monitoring of CAR-T Cell Applications. https://app.cochat.ai/papers/10.3389/fimmu.2021.658314
The paper
Blache, U., Weiss, R., Boldt, A., Kapinsky, M., Blaudszun, A.-R., Quaiser, A., Pohl, A., Miloud, T., Burgaud, M., Vucinic, V., Platzbecker, U., Sack, U., Fricke, S., & Koehl, U. (2021). Advanced Flow Cytometry Assays for Immune Monitoring of CAR-T Cell Applications. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2021.658314

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.